Immunotherapy’s Impact on the Mesothelioma Immune System
The battle against mesothelioma has seen significant developments in recent years. Many developments are with the introduction of immunotherapy as…
The Persistence of Mesothelioma in a Post-Asbestos Era
Mesothelioma is a type of cancer caused by exposure to a harmful mineral called asbestos. It takes decades for mesothelioma…
Tailoring Mesothelioma Treatment with Accurate Subtype Identification
A new study is exploring a new method for classifying mesothelioma subtypes. It offers hope for more accurate diagnoses and…
Unveiling the Rare: Pericardial and Peritoneal Mesothelioma
Mesotheliomas are a rare type of cancer caused by exposure to asbestos. Mesothelioma in the lungs is called pleural mesothelioma…
Can Brain Natriuretic Peptide Predict Mesothelioma Outcomes?
Researchers have been looking at a substance called Brain Natriuretic Peptide to find out if it could predict survival in…
Uncovering the Secrets of Long-Term Survival in Pleural Mesothelioma: The DNA Repair Factor
DNA repair plays an important role in a type of cancer called malignant pleural mesothelioma. Scientists have found that mesothelioma…
How Inflammation, Stress, and Signaling Shape Mesothelioma’s Growth
Scientists are looking at how long-term inflammation, cell stress, and messed-up cell signaling help mesothelioma cancer cells grow and spread.…
Empowering Mesothelioma Patients with Patient-Reported Symptom Monitoring
New data shows that patient-reported symptom monitoring improves the quality of life in lung cancer patients. The study was published…
New Hope for Mesothelioma Patients in Intensive Care
In the fight against mesothelioma, there’s new and hopeful data that might help patients who end up in the intensive…
Diagnosis | Europe | International | Prognosis | Treatments
Examining the Hype: Lackluster Performance of New Mesothelioma Treatment
Researchers have found that povidone-iodine treatment does not improve survival in mesothelioma patients. The study comes from King’s College and…